Growth Metrics

Rxo (RXO) Net Margin (2021 - 2025)

Rxo (RXO) has disclosed Net Margin for 5 consecutive years, with 3.13% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 163.0% year-over-year to 3.13%, compared with a TTM value of 1.74% through Dec 2025, up 463.0%, and an annual FY2025 reading of 1.74%, up 463.0% over the prior year.
  • Net Margin was 3.13% for Q4 2025 at Rxo, down from 0.99% in the prior quarter.
  • Across five years, Net Margin topped out at 3.59% in Q2 2022 and bottomed at 23.37% in Q3 2024.
  • Average Net Margin over 5 years is 1.45%, with a median of 0.5% recorded in 2022.
  • The sharpest move saw Net Margin tumbled -2326bps in 2024, then skyrocketed 2238bps in 2025.
  • Year by year, Net Margin stood at 3.17% in 2021, then plummeted by -111bps to 0.36% in 2022, then skyrocketed by 157bps to 0.2% in 2023, then tumbled by -833bps to 1.5% in 2024, then plummeted by -109bps to 3.13% in 2025.
  • Business Quant data shows Net Margin for RXO at 3.13% in Q4 2025, 0.99% in Q3 2025, and 0.63% in Q2 2025.